Eximis is focused on delivering contained specimen removal solutions that provide a safe and efficient solution for patients andpractitioners. Meet the experienced leadership team that is committed to bringing this innovative platform to market.
Donna Ford-Serbu, CEO
22 years in the medical device industry (Covidien, Spectranetics); General Manager, Sales & Marketing, Business Development, Strategy.
Bob Luzzi, Vice President of R&D
Bob has over 29 years in the medical device industry; Bob is an inventor on 50 pending patents and is a Certified Patent Agent.
Hilary Baldwin, VP Regulatory and Clinical Affairs
20 years' experience in regulatory and quality in the pharmaceutical, diagnostic, and medical device industries.
William Gregg, Director of R&D
25 years in the medical device industry (Fisher Imaging, Covidien); Led Covidien generator R&D group (>$610M annual revenue)
Chris Underwood, Director of Operations
16 years of medical device (Cardinal Health, Medtronic, Covidien, and Mountainside Medical); Director of Engineering, Mechanical engineering Manager (R&D)
Eximis Board of Directors
Ryan Drant
- Founder and Managing Director at Questa Capital
- Healthcare investment specialist
- Served on 35 board of directors
Scott Button
- Managing Director of Venture Investors
- Over 15 years of portfolio company board experience
Scott Hutton
- Currently CEO, BIODESIX, INC
- 16 YRS Medical Device Experience
- VP AND GM MEDTRONIC NEUROSURGERY 2012-2017
Ted Lamson
- Co-Founder, CEO, CTO of NeoTract (acquired by Teleflex)
- Over 25 yrs in medical devices
- Deep start-up experience
Donna Ford-Serbu, CEO
- 21 years in the medical device industry (Covidien, Spectranetics)
- General Manager, Sales & Marketing, Business Development, Strategy
Brian Butler
- Partner, Questa Capital
- Medical device, life sciences investment specialist